My Intelligent Machines Inc.

My Intelligent Machines Inc.

(MIMs) is a Montreal-based company that specializes in artificial intelligence and systems biology. Founded in 2016, MIMs focuses on providing augmented intelligence solutions for the biopharma and agritech industries. The company aims to enable precise biological simulations and the development of targeted, personalized therapies. MIMs offers a Software-as-a-Service (SaaS) platform that features a range of tools, including biological simulation software, therapeutic target and biomarker selection systems, and patient stratification solutions. Their oncology and immuno-oncology platform includes modules designed specifically for drug development. Additionally, MIMs provides a data integration platform that utilizes bioinformatics and machine learning to help life-science companies manage and interpret large datasets. The company primarily serves biopharma and agritech companies, as well as life scientists, hospitals, and universities. MIMs is recognized for its innovative approach to reverse translational research, delivering results more efficiently and cost-effectively than traditional methods.